Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Critical RiskFDA Device
Medical Devices

Fresenius Kabi USA, LLC: Ivenix Infusion System Software Recalled for Potential Dosing Errors

Agency Publication Date: April 11, 2024
Share:
Sign in to monitor this recall

Summary

Fresenius Kabi USA is recalling the LVP Software of the Ivenix Infusion System (IIS) version 5.8.0, affecting 17 units. The software contains anomalies that can cause the pump to deliver too much or too little medication, or cause a delay in starting life-sustaining therapy. While no specific injuries are reported in this data, these software issues could lead to serious patient harm or death. This system is used in healthcare settings to deliver fluids and medications to patients.

Risk

Software defects may cause the device to malfunction, resulting in a patient receiving an incorrect dose of medication or a critical delay in therapy, which can lead to life-threatening medical complications.

What You Should Do

  1. Identify if your facility is using the Ivenix Infusion System (IIS) with LVP Software version 5.8.0 (Product LVP-SW-0004; UDI-DI 00811505030122).
  2. If you are using the affected software, contact your healthcare provider or Fresenius Kabi USA for technical guidance and to schedule a software update.
  3. Check the device display or system settings to confirm the software version number matches 5.8.0 before continuing use.
  4. Contact Fresenius Kabi USA directly for further instructions regarding potential corrective actions or refunds related to this software anomaly.
  5. For additional questions or to report issues, contact the FDA at 1-888-463-6332 (1-888-INFO-FDA) or visit www.fda.gov/medical-devices/medical-device-recalls.

Your Remedy Options

๐Ÿ“‹Other Action

Manufacturer corrective action and professional guidance

How to: Contact your healthcare provider or the manufacturer for further instructions and potential refund

Affected Products

Product: LVP Software of the Ivenix Infusion System (IIS), Version 5.8.0.
Model / REF:
LVP-SW-0004
UDI-DI 00811505030122

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 94228
Status: Active
Manufacturer: Fresenius Kabi USA, LLC
Sold By: Direct distribution
Manufactured In: United States
Units Affected: 17 units
Distributed To: California, Colorado, Idaho, Michigan, Nebraska, New Jersey, Nevada, Oklahoma, Texas, Utah, Virginia, Washington, Wisconsin

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.